Abiopharma

🔍 Juran David B. (Executive)

Company: Bridgewater Bancshares Inc (BWB)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Sold 15,000 shares of Common Stock at $21.5924 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 106,301.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 25,000 shares of Common Stock at $21.7372 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 81,301.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 10,725.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 95,307.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 16,328.00 | Footnotes: F6
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: H | shares_owned_after: 1,349,926.00

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.55 to $21.67, inclusive. The reporting person undertakes to provide to Bridgewater Bancshares, Inc., any security holder of Bridgewater Bancshares, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote to this Form 4.
• F2: Shares of common stock are held by Mr. Juran as trustee of Marital Trust 2 under a trust agreement dated September 17, 2018.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.58 to $21.84, inclusive. The reporting person undertakes to provide to Bridgewater Bancshares, Inc., any security holder of Bridgewater Bancshares, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote to this Form 4.
• F4: Shares of common stock are held by Mr. Juran as co-trustee of a Residuary Trust dated June 18, 2002. Mr. Juran possesses shared voting and investment power with respect to the shares of common stock held under the trust.
• F5: Mr. Juran is attorney-in-fact for a trustee who holds the shares of common stock as trustee of a Revocable Trust dated January 31, 2014. Mr. Juran is not a trustee of the trust, however Mr. Juran may possess investment power with respect to the shares of common stock held under the trust.
• F6: Shares of common stock are held by Mr. Juran as trustee of Descendant's Separate Trust under a trust agreement dated September 17, 2018.